Home

George Magrath

CIK 1999390 · Chief Executive Officer · last filed 2026-04-27

George Magrath is a Chief Executive Officer who has filed 17 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for IRD, was dated Jul 23, 2026. Across all open-market trades the lifetime net is +$79.6K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

17

Lifetime Open-Market Net

$79.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Opus Genetics, Inc. (OCUP) Delisted Chief Executive Officer 1,741,344 $1.17 $2.04M $79.6K 14 2026-04-27

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-23 IRD Notice (144) −9,475 -$28.9K EDGAR
2026-04-27 Opus Genetics, Inc. (OCUP) Delisted Sell (S) −9,511 -$49.6K EDGAR
2026-04-23 IRD Notice (144) −9,511 -$127.3K EDGAR
2026-03-18 Opus Genetics, Inc. (OCUP) Delisted Sell (S) −24,438 -$127.3K EDGAR
2026-03-16 IRD Notice (144) −24,438 -$127.3K EDGAR
2026-01-26 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +483,639 $0 EDGAR
2025-11-05 Opus Genetics, Inc. (OCUP) Delisted Tax (F) −30,350 -$69.8K EDGAR
2025-11-04 Opus Genetics, Inc. (OCUP) Delisted Tax (F) −30,350 -$69.8K EDGAR
2025-03-26 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +392,157 $0 EDGAR
2025-03-17 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +330,697 $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.